Development of atropisomeric 5 <i>N</i> -sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase

Hidetsugu Tabata, Yoshiki Miyata, Yoshio Kusakabe, Hideyo Takahashi, Hideaki Natsugari, Tetsuta Oshitari

Open source

DOI
10.1039/d6md00430j
Published
2026
Container
RSC Medicinal Chemistry
Publisher
Royal Society of Chemistry (RSC)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6md00430j,
  title = {Development of atropisomeric 5
                    <i>N</i>
                    -sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase},
  author = {Hidetsugu Tabata and Yoshiki Miyata and Yoshio Kusakabe and Hideyo Takahashi and Hideaki Natsugari and Tetsuta Oshitari},
  year = {2026},
  journal = {RSC Medicinal Chemistry},
  doi = {10.1039/d6md00430j},
  url = {https://doi.org/10.1039/d6md00430j}
}

RIS

TY  - JOUR
TI  - Development of atropisomeric 5
                    <i>N</i>
                    -sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase
AU  - Hidetsugu Tabata
AU  - Yoshiki Miyata
AU  - Yoshio Kusakabe
AU  - Hideyo Takahashi
AU  - Hideaki Natsugari
AU  - Tetsuta Oshitari
PY  - 2026
JO  - RSC Medicinal Chemistry
DO  - 10.1039/d6md00430j
UR  - https://doi.org/10.1039/d6md00430j
ER  - 

APA

Tabata, H., Miyata, Y., Kusakabe, Y., Takahashi, H., Natsugari, H., & Oshitari, T. (2026). Development of atropisomeric 5 <i>N</i> -sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00430j

Source records